OpGen

OPGNPre-clinical

OpGen is a US-based public company focused on addressing the global antimicrobial resistance (AMR) crisis through advanced diagnostics and data analytics. Its core offerings include the Acuitas AMR Gene Panel and the Unyvero platform for rapid detection of pathogens and resistance markers. The company's strategy involves integrating molecular diagnostics with bioinformatics to guide targeted antibiotic therapy and support infection control programs in hospitals.

Market Cap

$242.7M

Employees

50-100

Focus

Biotech

OPGN · Stock Price

USD 23.91128.51 (-84.31%)

Historical price data

AI Company Overview

Technology Platform

Integrated molecular diagnostics and bioinformatics platform for rapid pathogen identification and antimicrobial resistance (AMR) gene detection, coupled with data analytics software for infection control and stewardship.

Opportunities

The growing global mandate for antimicrobial stewardship programs in hospitals creates a direct, reimbursable demand for OpGen's rapid diagnostic and data analytics solutions.

Expansion of FDA clearances for the Unyvero platform in the U.S.

market represents a significant near-term revenue opportunity.

Potential partnerships with pharmaceutical companies developing novel antibiotics could provide co-commercialization opportunities and non-dilutive funding.

Risk Factors

OpGen faces significant financial risk due to its history of operating losses and dependence on external financing.

Intense competition from larger, well-capitalized diagnostics companies poses a major threat to market share.

Regulatory delays or denials from the FDA for key product submissions would severely hinder U.S.

growth prospects and could impact the company's viability.

Competitive Landscape

OpGen competes with large diagnostics firms like BioMérieux (BioFire), Cepheid (Danaher), and Becton Dickinson, which have broader portfolios and greater commercial scale. Its differentiation lies in a specialized focus on genetic antibiotic resistance detection and an integrated software platform for hospital-wide AMR data analytics, aiming to provide actionable intelligence beyond single test results.